Market Insights report
The Sensory Organ Drugs market covers ophthalmologicals and otologicals, i.e., drugs for the sensory organs eye and ear, respectively. Ophthalmologicals are used to treat diseases of the eye such as wet age-related macular degeneration, geographic atrophy, and glaucoma. Typical dosage forms are eye drops or injections into the eye (intravitreal) and, in the case of otologicals, through the eardrum into the middle ear.
What's included?
In the market Sensory Organ Drugs, ophthalmologicals have a much larger share than otologicals. The solid growth of the market is expected to be somewhat weakened by expiring patents, e.g., in the case of Eylea in 2026. Nevertheless, mid-term growth is predicted to stay fairly high and stable. The main market drivers are an aging population combined with a growing awareness of diseases of the eye and ear and increasing advancements in technology. A substantial fraction of the market comprises only a few different drugs to treat severe eye conditions.
Overview
Market numbers
We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)